Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11632)
All Articles published online
|
Publishing Process of This Article
|
Apr 18, 2015 (publication date) through May 7, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Barth H. Hepatitis C virus: Is it time to say goodbye yet? Perspectives and challenges for the next decade. World J Hepatol 2015; 7(5): 725-737 [PMID: 25914773 DOI: 10.4254/wjh.v7.i5.725] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i5/725.htm |
| Number | Citing Articles |
| 1 |
Urbano Sbarigia, Daniel Wirth, Karen Van Nuys, Caroline Huber, Ron Brookmeyer, Jona Stahmeyer, Christian Krauth. Economic study of the value of expanding HCV treatment capacity in Germany. BMJ Open Gastroenterology 2017; 4(1): e000130 doi: 10.1136/bmjgast-2016-000130
|
| 2 |
Alireza Rafati, Hadi Esmaeili Gouvarchin Ghaleh, Afsaneh Azarabadi, Mahmood Reza Masoudi, Elmira Afrasiab, Akbar Ghorbani Alvanegh. Stem cells as an ideal carrier for gene therapy: A new approach to the treatment of hepatitis C virus. Transplant Immunology 2022; 75: 101721 doi: 10.1016/j.trim.2022.101721
|
| 3 |
Mohammad Enamul Hoque Kayesh, Sayeh Ezzikouri, Takahiro Sanada, Haiying Chi, Yukiko Hayashi, Khadija Rebbani, Bouchra Kitab, Aya Matsuu, Noriaki Miyoshi, Tsunekazu Hishima, Michinori Kohara, Kyoko Tsukiyama-Kohara. Oxidative Stress and Immune Responses During Hepatitis C Virus Infection in Tupaia belangeri
. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-10329-7
|
| 4 |
Ewelina Krol, Gabriela Pastuch-Gawolek, Binay Chaubey, Gabriela Brzuska, Karol Erfurt, Boguslaw Szewczyk. Novel Uridine Glycoconjugates, Derivatives of 4-Aminophenyl 1-Thioglycosides, as Potential Antiviral Compounds. Molecules 2018; 23(6): 1435 doi: 10.3390/molecules23061435
|
| 5 |
Timothy T Spear, Timothy P Riley, Gretchen E Lyons, Glenda G Callender, Jeffrey J Roszkowski, Yuan Wang, Patricia E Simms, Gina M Scurti, Kendra C Foley, David C Murray, Lance M Hellman, Rachel H McMahan, Makio Iwashima, Elizabeth Garrett-Mayer, Hugo R Rosen, Brian M Baker, Michael I Nishimura. Hepatitis C virus-cross-reactive TCR gene-modified T cells: a model for immunotherapy against diseases with genomic instability. Journal of Leukocyte Biology 2016; 100(3): 545 doi: 10.1189/jlb.2A1215-561R
|
| 6 |
José M. Benito, Javier García-Samaniego, Marcial García, Antonio Madejón, Luz Martín-Carbonero, Alfonso Cabello, Beatriz Álvarez, Miguel Górgolas, Norma Rallón. Both Hepatitis C Virus-Specific T Cell Responses andIL28Brs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C. Journal of Interferon & Cytokine Research 2017; 37(6): 278 doi: 10.1089/jir.2016.0078
|
| 7 |
Ascensión Ariza-Mateos, Rosa Díaz-Toledano, Timothy M. Block, Samuel Prieto-Vega, Alex Birk, Jordi Gómez. Geneticin Stabilizes the Open Conformation of the 5′ Region of Hepatitis C Virus RNA and Inhibits Viral Replication. Antimicrobial Agents and Chemotherapy 2016; 60(2): 925 doi: 10.1128/AAC.02511-15
|
| 8 |
Violeta Lara-Aguilar, Daniel Valle-Millares, Celia Crespo-Bermejo, Sergio Grande-García, Manuel Llamas-Adán, María Engracia Cortijo-Alfonso, Luz Martín-Carbonero, Lourdes Domínguez, Pablo Ryan, Ignacio de los Santos, Sofía Bartolomé-Sánchez, Erick Joan Vidal-Alcántara, María Angeles Jiménez-Sousa, Amanda Fernández-Rodríguez, Verónica Briz. Dynamics of cellular senescence markers after HCV elimination spontaneously or by DAAs in people living with HIV. Biomedicine & Pharmacotherapy 2023; 162: 114664 doi: 10.1016/j.biopha.2023.114664
|
| 9 |
|
| 10 |
Pier Angelo Tovo, Stefania Bezzio, Clara Gabiano. Neonatology. 2018; : 1681 doi: 10.1007/978-3-319-29489-6_251
|
| 11 |
Alok Kumar Moharana, Rudra Narayan Dash, Bharat Bhusan Subudhi. Thiosemicarbazides: Updates on Antivirals Strategy. Mini-Reviews in Medicinal Chemistry 2021; 20(20): 2135 doi: 10.2174/1389557520666200818212408
|
| 12 |
Pier-Angelo Tovo, Carmelina Calitri, Carlo Scolfaro, Clara Gabiano, Silvia Garazzino. Vertically acquired hepatitis C virus infection: Correlates of transmission and disease progression. World Journal of Gastroenterology 2016; 22(4): 1382-1392 doi: 10.3748/wjg.v22.i4.1382
|
| 13 |
Jacqueline D. Reeves, Neil T. Parkin. Antimicrobial Drug Resistance. 2017; : 1389 doi: 10.1007/978-3-319-47266-9_35
|
| 14 |
Ozge Cevik, Dan Li, Erdene Baljinnyam, Dinesh Manvar, Erica M. Pimenta, Gulam Waris, Betsy J. Barnes, Neerja Kaushik-Basu. Interferon regulatory factor 5 (IRF5) suppresses hepatitis C virus (HCV) replication and HCV-associated hepatocellular carcinoma. Journal of Biological Chemistry 2017; 292(52): 21676 doi: 10.1074/jbc.M117.792721
|
| 15 |
|
| 16 |
Ahmed Lasfar, Andrew Zloza, Karine A. Cohen-Solal. IFN-lambda therapy: current status and future perspectives. Drug Discovery Today 2016; 21(1): 167 doi: 10.1016/j.drudis.2015.10.021
|
| 17 |
Keanan McGonigle, Tess Carley, Clarissa Hoff. Assessing Racial Disparities in HCV Infection and Care Outcomes in a Southern Urban Population. Journal of Racial and Ethnic Health Disparities 2018; 5(5): 1052 doi: 10.1007/s40615-017-0453-y
|
| 18 |
Jacqueline Farinha Shimizu, Caroline Sprengel Lima, Carina Machado Pereira, Cintia Bittar, Mariana Nogueira Batista, Ana Carolina Nazaré, Carlos Roberto Polaquini, Carsten Zothner, Mark Harris, Paula Rahal, Luis Octávio Regasini, Ana Carolina Gomes Jardim. Flavonoids from Pterogyne nitens Inhibit Hepatitis C Virus Entry. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-16336-y
|
| 19 |
Yu-Ming Lee, Yulander Duh, Shih-Ting Wang, Michael M.C. Lai, Hanna S. Yuan, Carmay Lim. Using an Old Drug to Target a New Drug Site: Application of Disulfiram to Target the Zn-Site in HCV NS5A Protein. Journal of the American Chemical Society 2016; 138(11): 3856 doi: 10.1021/jacs.6b00299
|
| 20 |
Erofili Giannakopoulou, Vasiliki Pardali, Efseveia Frakolaki, Vasileios Siozos, Vassilios Myrianthopoulos, Emmanuel Mikros, Martin C. Taylor, John M. Kelly, Niki Vassilaki, Grigoris Zoidis. Scaffold hybridization strategy towards potent hydroxamate-based inhibitors ofFlaviviridaeviruses andTrypanosomaspecies. MedChemComm 2019; 10(6): 991 doi: 10.1039/C9MD00200F
|
| 21 |
Hanan H. Rizk, Nadia M. Hamdy, Nadia L. Al-Ansari, Hala O. El-Mesallamy, Ming-Lung Yu. Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4. PLOS ONE 2016; 11(4): e0153895 doi: 10.1371/journal.pone.0153895
|
| 22 |
Ewelina Krol, Ilona Wandzik, Gabriela Pastuch-Gawolek, Boguslaw Szewczyk. Anti-Hepatitis C Virus Activity of Uridine Derivatives of 2-Deoxy Sugars. Molecules 2018; 23(7): 1547 doi: 10.3390/molecules23071547
|
| 23 |
A. Ferreira-Gonzalez. Diagnostic Molecular Pathology. 2017; : 485 doi: 10.1016/B978-0-12-800886-7.00038-8
|
| 24 |
Farina M Hanif, Zain Majid, Nasir Hassan Luck, Abbas Ali Tasneem, Syed Muddasir Laeeq, Muhammed Mubarak. Revolution in the diagnosis and management of hepatitis C virus infection in current era. World Journal of Hepatology 2022; 14(4): 647-669 doi: 10.4254/wjh.v14.i4.647
|
| 25 |
Parisa Shiri Aghbash, Nima Hemmat, Javid Sadri Nahand, Ali Shamekh, Mohammad Yousef Memar, Abouzar Babaei, Hossein Bannazadeh Baghi. The role of Th17 cells in viral infections. International Immunopharmacology 2021; 91: 107331 doi: 10.1016/j.intimp.2020.107331
|
| 26 |
Ankush Kumar, Raj Kumar Narang, Rohit Bhatia. Recent advancements in NS5B inhibitors (2011-2021): Structural insights, SAR studies and clinical status. Journal of Molecular Structure 2023; 1293: 136272 doi: 10.1016/j.molstruc.2023.136272
|
| 27 |
Lize Cuypers, Guangdi Li, Pieter Libin, Supinya Piampongsant, Anne-Mieke Vandamme, Kristof Theys. Genetic Diversity and Selective Pressure in Hepatitis C Virus Genotypes 1–6: Significance for Direct-Acting Antiviral Treatment and Drug Resistance. Viruses 2015; 7(9): 5018 doi: 10.3390/v7092857
|
| 28 |
|
| 29 |
Milena S. Cabral, Taciana P.S. Santos, Priscila L. Santos, Maria Isabel Schinoni, Isabela S. Oliveira, Ariana B. Pereira, Ajax M. Atta, Maria Luiza B. Sousa-Atta. Immune response of Th17-associated cytokines by peripheral blood mononuclear cells from patients with chronic hepatitis C virus infection. Cytokine 2018; 102: 200 doi: 10.1016/j.cyto.2017.09.015
|
| 30 |
Nikolaos Lougiakis, Efseveia Frakolaki, Panagiota Karmou, Nicole Pouli, Panagiotis Marakos, Vanesa Madan, Ralf Bartenschlager, Niki Vassilaki. Novel nucleoside analogues targeting HCV replication through an NS5A‐dependent inhibition mechanism. Chemical Biology & Drug Design 2017; 90(3): 352 doi: 10.1111/cbdd.12966
|
| 31 |
Pier-Angelo Tovo, Stefania Bezzio, Clara Gabiano. Neonatology. 2017; : 1 doi: 10.1007/978-3-319-18159-2_251-1
|
| 32 |
Shunhua Guo, Meghan E Kapp, Diego M Beltran, Cesar Y Cardona, Dawn J Caster, Ronald R Reichel, Agnes B Fogo. Spectrum of Kidney Diseases in Patients With Hepatitis C Virus Infection. American Journal of Clinical Pathology 2021; 156(3): 399 doi: 10.1093/ajcp/aqaa238
|
| 33 |
J. D. Leask, J. F. Dillon. Review article: treatment as prevention – targeting people who inject drugs as a pathway towards hepatitis C eradication. Alimentary Pharmacology & Therapeutics 2016; 44(2): 145 doi: 10.1111/apt.13673
|
| 34 |
Neerja Kaushik-Basu, Nina K. Ratmanova, Dinesh Manvar, Dmitry S. Belov, Ozge Cevik, Amartya Basu, Mark M. Yerukhimovich, Evgeny R. Lukyanenko, Ivan A. Andreev, Grigory M. Belov, Giuseppe Manfroni, Violetta Cecchetti, David N. Frick, Alexander V. Kurkin, Andrea Altieri, Maria Letizia Barreca. Bicyclic octahydrocyclohepta[ b ]pyrrol-4(1 H )one derivatives as novel selective anti-hepatitis C virus agents. European Journal of Medicinal Chemistry 2016; 122: 319 doi: 10.1016/j.ejmech.2016.06.041
|
| 35 |
Weifeng Gong, Xiaobo Guo, Yangmin Zhang. Depletion of MicroRNA-373 Represses the Replication of Hepatitis C Virus via Activation of Type 1 Interferon Response by Targeting IRF5. Yonsei Medical Journal 2018; 59(10): 1181 doi: 10.3349/ymj.2018.59.10.1181
|
| 36 |
Celia Perales, Josep Quer, Josep Gregori, Juan Esteban, Esteban Domingo. Resistance of Hepatitis C Virus to Inhibitors: Complexity and Clinical Implications. Viruses 2015; 7(11): 5746 doi: 10.3390/v7112902
|
| 37 |
A. Stubbs, P. Naylor, K. Ravindran, S. Benjaram, N. Reddy, S. Mutchnick, E. May, M. Ehrinpreis, M. Mutchnick. Racial diversity in mortality and morbidity in urban patients with hepatitis C. Journal of Viral Hepatitis 2016; 23(6): 439 doi: 10.1111/jvh.12504
|
| 38 |
Reza Taherkhani, Fatemeh Farshadpour. Epidemiology of hepatitis C virus in Iran. World Journal of Gastroenterology 2015; 21(38): 10790-10810 doi: 10.3748/wjg.v21.i38.10790
|
| 39 |
Hazel Tapp, Thomas Ludden, Lindsay Shade, Jeremy Thomas, Sveta Mohanan, Michael Leonard. Electronic medical record alert activation increase hepatitis C and HIV screening rates in primary care practices within a large healthcare system. Preventive Medicine Reports 2020; 17: 101036 doi: 10.1016/j.pmedr.2019.101036
|
| 40 |
Ikram Sghaier, Etienne Brochot, Besma Y. Loueslati, Wassim Y. Almawi. Hepatitis C virus protein interaction network for HCV clearance and association of DAA to HCC occurrence via data mining approach: A systematic review and critical analysis. Reviews in Medical Virology 2019; 29(2) doi: 10.1002/rmv.2033
|
| 41 |
Zhen-Xi Niu, Peng Nie, Piet Herdewijn, Ya-Tao Wang. Synthetic approaches and application of clinically approved small-molecule drugs to treat hepatitis. European Journal of Medicinal Chemistry 2023; 262: 115919 doi: 10.1016/j.ejmech.2023.115919
|
| 42 |
John D Groopman. Environmental health in the biology century: Transitions from population to personalized prevention. Experimental Biology and Medicine 2019; 244(9): 728 doi: 10.1177/1535370219837903
|
| 43 |
Ikram Sghaier, Leila Mouelhi, Ezzedine Ghazoueni, Etienne Brochot, Wassim Y. Almawi, Besma Yacoubi-Loueslati. Role of TLRs and IL-6 in the outcome of chronic hepatitis C treatment in Tunisian population. Cytokine 2017; 99: 297 doi: 10.1016/j.cyto.2017.08.010
|
| 44 |
Maria C Sorbo, Luca Carioti, Maria C Bellocchi, FrancescoPaolo Antonucci, Daniele Sforza, Ilaria Lenci, Matteo Ciancio Manuelli, Daniele Armenia, Francesco De Leonardis, Martina Milana, Tommaso M Manzia, Mario Angelico, Giuseppe Tisone, Valeria Cento, Carlo F Perno, Francesca Ceccherini‐Silberstein. HCV resistance compartmentalization within tumoral and non‐tumoral liver in transplanted patients with hepatocellular carcinoma. Liver International 2019; 39(10): 1986 doi: 10.1111/liv.14168
|